Inulin and Mood: The EFFICAD Trial and What It Actually Showed

The EFFICAD trial, published in the American Journal of Clinical Nutrition in 2023, randomized 92 healthy adults with mild to moderate anxiety and depression to oligofructose 8 grams a day, 2-fucosyllactose, both, or placebo for five weeks. The oligofructose groups showed significant improvements in Beck Depression Inventory, State Trait Anxiety Inventory, and Positive and Negative Affect Schedule scores, alongside increases in Bifidobacterium, Roseburia, and Faecalibacterium prausnitzii. It is the best trial of a prebiotic for mood, and it is one trial.

Your gut makes neurotransmitters. That sentence has launched a thousand supplement claims, and most of them deserve the skepticism they get. The gut-brain axis is real: two-way communication between gut and brain through neural, hormonal, and immune pathways, with gut microbes involved in producing serotonin and other signaling molecules. But a real axis is not the same as a working intervention, and the difference between the two is a randomized trial. For inulin-type fructans and mood, there is now one worth reading carefully.

The EFFICAD trial ran for five weeks in 92 healthy adults with mild to moderate anxiety and depression. Four arms: oligofructose 8 grams a day, 2-fucosyllactose 2 grams a day, both together, or maltodextrin placebo. The researchers measured mood with the Beck Depression Inventory, the State Trait Anxiety Inventory, and the Positive and Negative Affect Schedule, and they measured the microbiome alongside. The results were positive, and the details are what make them interesting.

What improved, and by how much

Significant improvements in depression, anxiety, and affect scores appeared across the oligofructose, 2-fucosyllactose, and combination groups. Both sole oligofructose and the oligofructose plus 2-fucosyllactose combination outperformed sole 2-fucosyllactose and maltodextrin on several mood parameters. The microbiome moved too: significant increases in Bifidobacterium, Bacteroides, Roseburia, and Faecalibacterium prausnitzii in both oligofructose arms. Cortisol awakening response, a stress hormone measure, also improved. The improvements appeared within 28 days, which is fast for a dietary intervention, and the study's lead microbiologist, Professor Bob Rastall of the University of Reading, has said the dose that worked was 8 grams a day of oligofructose from chicory root.

That dose matters, because it is higher than the dose most people take for digestive health. Rastall recommends starting at about 3 grams of chicory root fiber a day for general digestive health, but the mood effect in EFFICAD came at 8 grams. Eight grams of a fermentable fiber is also enough to cause real bloating in the first weeks, which is the practical reason the ramp matters: start low, increase weekly, and back down if symptoms worsen. A dose you quit in week two helps no one's mood.

What the wider evidence says

EFFICAD is one trial, and the meta-analyses around it tell a more cautious story. A 2025 meta-analysis of 72 randomized controlled trials found probiotics, prebiotics, and synbiotics significantly reduced depression, with a standardized mean difference of negative 0.53, and anxiety at negative 0.44, and improved sleep. But the heterogeneity was high, and the authors called for larger, higher-quality trials with long-term follow-up. A separate 2025 meta-analysis in clinically diagnosed samples found probiotics reduced depression substantially and anxiety moderately, while prebiotics alone did not show a significant effect on depression, with a standardized mean difference of negative 0.28 and a confidence interval crossing zero.

The split is the story. Probiotics have the stronger record for clinical depression. Prebiotics have one good trial in healthy adults with mild symptoms, and a nonsignificant trend in clinical samples. That does not make EFFICAD wrong. It makes it specific: oligofructose at 8 grams a day, in healthy adults with mild to moderate anxiety and depression, over five weeks, with mood and microbiome moving together. Extrapolating it to major depression, or to a different fiber at a different dose, is exactly the kind of leap the trial does not support.

The honest takeaway

Inulin-type fructans are a reasonable, low-risk addition to a routine for someone with mild anxiety or low mood who also wants the digestive benefits, and the 8-gram dose is the one with data behind it. They are not a treatment for depression. The effect size is modest, the trial is one, and the people it helped were healthy adults with mild symptoms, not patients. Anyone with clinical depression should treat the gut as an adjunct to real care, not a substitute for it.

The reason this post exists is that EFFICAD is the rare prebiotic trial that did the work properly: randomized, double-blind, placebo-controlled, with the microbiome measured alongside the mood. Most of the claims in this space have nothing behind them. This one has 92 people, five weeks, and a dose. That is enough to take seriously, and not enough to oversell.

Frequently asked questions

Can inulin improve mood?

One good trial says yes, modestly. The EFFICAD trial found 8 grams a day of oligofructose improved depression and anxiety scores over five weeks in 92 healthy adults with mild to moderate symptoms. Prebiotics alone did not show a significant effect on depression in a separate meta-analysis of clinical samples, so the evidence is specific, not general.

How much inulin do I need for mood benefits?

The EFFICAD trial used 8 grams a day of oligofructose from chicory root. For general digestive health, about 3 grams a day is the usual starting recommendation. Eight grams of fermentable fiber can cause bloating at first, so ramp up weekly rather than starting at the full dose.

How does gut bacteria affect mood?

Through the gut-brain axis, two-way communication via neural, hormonal, and immune pathways. Gut microbes help produce neurotransmitters like serotonin, and prebiotics feed beneficial bacteria that produce short-chain fatty acids, which affect brain function. The EFFICAD trial linked mood improvement to increases in Bifidobacterium, Roseburia, and Faecalibacterium prausnitzii.

Is inulin a treatment for depression?

No. The evidence supports a modest benefit for mild symptoms in healthy adults, not a treatment for clinical depression. Probiotics have a stronger record for clinical depression than prebiotics. Anyone with depression should treat gut interventions as an adjunct to proper care.